MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$82,081K
Unrealized gain on
marketable securities
$46K
Net loss
-$82,127K
Interest income
$9,756K
Net loss before
income taxes
-$81,625K
Income tax expense
$502K
Total other income,
net
$9,513K
License
$17,500K
Product
$1,588K
Other (expense)
income
-$243K
Loss from operations
-$91,138K
Total revenue
$19,088K
Total operating
expenses
$110,226K
Selling, general and
administrative
$91,138K
Research and development
$18,670K
Cost of sales
$418K
Back
Back
Income Statement
source: myfinsight.com
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)